|
ANKS1A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.30866494996963E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
2.06300000005211E-06 |
| Normal-vs-Stage3 |
4.00690591817465E-12 |
| Normal-vs-Stage4 |
7.4273920347423E-13 |
| Stage1-vs-Stage2 |
1.357780E-01 |
| Stage1-vs-Stage3 |
2.163400E-01 |
| Stage1-vs-Stage4 |
4.522000E-02 |
| Stage2-vs-Stage3 |
2.739600E-02 |
| Stage2-vs-Stage4 |
1.114440E-02 |
| Stage3-vs-Stage4 |
4.453800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.990070E-04 |
| Normal-vs-Asian |
3.99229538317059E-11 |
| Caucasian-vs-AfricanAmerican |
1.381030E-01 |
| Caucasian-vs-Asian |
5.024400E-01 |
| AfricanAmerican-vs-Asian |
6.333500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.71196390397199E-13 |
| Normal-vs-Female |
1.60349511446611E-11 |
| Male-vs-Female |
5.395400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.01999528215424E-11 |
| Normal-vs-Age(41-60Yrs) |
3.77475828372553E-15 |
| Normal-vs-Age(61-80Yrs) |
4.15759648930702E-11 |
| Normal-vs-Age(81-100Yrs) |
2.715200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.019600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.684400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.507600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.843600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.828200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.382600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.996800E-03 |
| Classical-VS-Follicular |
9.454800E-01 |
| Classical-VS-Other |
7.617200E-01 |
| Classical-VS-Normal |
1.0273004669159E-10 |
| Tall-VS-Follicular |
3.703800E-02 |
| Tall-VS-Other |
3.987000E-01 |
| Tall-VS-Normal |
8.74855743404623E-13 |
| Follicular-VS-Other |
7.541600E-01 |
| Follicular-VS-Normal |
2.3329005394146E-11 |
| Other-VS-Normal |
2.027500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.55191440096314E-15 |
| Normal-vs-N1 |
2.12879713856751E-11 |
| N0-vs-N1 |
7.086400E-02 |
|
|
